• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨保护素基因变异对急性心肌梗死和冠心病风险的因果效应:一项两样本孟德尔随机化研究。

Causal effects for genetic variants of osteoprotegerin on the risk of acute myocardial infarction and coronary heart disease: A two-sample Mendelian randomization study.

作者信息

Chao Peng, Zhang Xueqin, Zhang Lei, Cui Xinyue, Wang Shanshan, Yang Yining

机构信息

Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.

Department of Nephropathy, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.

出版信息

Front Cardiovasc Med. 2023 Mar 7;10:1041231. doi: 10.3389/fcvm.2023.1041231. eCollection 2023.

DOI:10.3389/fcvm.2023.1041231
PMID:36960470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10028206/
Abstract

Although since the 1980s, the mortality of coronary heart disease(CHD) has obviously decreased due to the rise of coronary intervention, the mortality and disability of CHD were still high in some countries. Etiological studies of acute myocardial infarction(AMI) and CHD were extremely important. In this study, we used two-sample Mendelian randomization(TSMR) method to collect GWAS statistics of osteoprotegerin (OPG), AMI and CHD to reveal the causal relationship between OPG and these two diseases. In total, we identified 7 genetic variants associated with AMI and 7 genetic variants associated with CHD that were not found to be in linkage disequilibrium(LD;  < 0.001). Evidence of a positive effect of an OPG genetic susceptibility on AMI was discovered(IVW OR = 0.877; 95% CI = 0.787-0.977;  = 0.017; 7 SNPs) and CHD (IVW OR = 0.892; 95% CI = 0.803-0.991;  = 0.033; 7 SNPs). After removing the influence of rs1385492, we found that there was a correlation between OPG and AMI/CHD (AMI: weighted median OR = 0.818;95% CI = 0.724-0.950;  = 0.001; 6SNPs;CHD: weighted median OR = 0.842; 95% CI = 0.755-0.938;  = 1.893 × 10; 6SNPs). The findings of our study indicated that OPG had a tight genetic causation association with MI or CHD. This genetic causal relationship presented us with fresh ideas for the etiology of AMI and CHD, which is an area of research that will continue in the future.

摘要

尽管自20世纪80年代以来,由于冠状动脉介入治疗的兴起,冠心病(CHD)的死亡率明显下降,但在一些国家,冠心病的死亡率和致残率仍然很高。急性心肌梗死(AMI)和冠心病的病因学研究极其重要。在本研究中,我们使用两样本孟德尔随机化(TSMR)方法收集骨保护素(OPG)、AMI和CHD的全基因组关联研究(GWAS)统计数据,以揭示OPG与这两种疾病之间的因果关系。我们总共鉴定出7个与AMI相关的基因变异和7个与CHD相关的基因变异,这些变异未发现处于连锁不平衡(LD;<0.001)状态。发现OPG基因易感性对AMI有正向影响的证据(逆方差加权法比值比[IVW OR]=0.877;95%置信区间[CI]=0.787-0.977;P=0.017;7个单核苷酸多态性[SNPs])以及对CHD有正向影响的证据(IVW OR=0.892;95%CI=0.803-0.991;P=0.033;7个SNPs)。在去除rs1385492的影响后,我们发现OPG与AMI/CHD之间存在相关性(AMI:加权中位数OR=0.818;95%CI=0.724-0.950;P=0.001;6个SNPs;CHD:加权中位数OR=0.842;95%CI=0.755-0.938;P=1.893×10;6个SNPs)。我们的研究结果表明,OPG与心肌梗死或冠心病存在紧密的遗传因果关联。这种遗传因果关系为AMI和CHD的病因学研究提供了新的思路,这是一个未来仍将继续的研究领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/10028206/df9340cfa2bf/fcvm-10-1041231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/10028206/835db0950195/fcvm-10-1041231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/10028206/df9340cfa2bf/fcvm-10-1041231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/10028206/835db0950195/fcvm-10-1041231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa1/10028206/df9340cfa2bf/fcvm-10-1041231-g002.jpg

相似文献

1
Causal effects for genetic variants of osteoprotegerin on the risk of acute myocardial infarction and coronary heart disease: A two-sample Mendelian randomization study.骨保护素基因变异对急性心肌梗死和冠心病风险的因果效应:一项两样本孟德尔随机化研究。
Front Cardiovasc Med. 2023 Mar 7;10:1041231. doi: 10.3389/fcvm.2023.1041231. eCollection 2023.
2
Genetically predicted osteoprotegerin levels and the risk of cardiovascular diseases: A Mendelian randomization study.基于遗传预测的骨保护素水平与心血管疾病风险:一项孟德尔随机研究。
Int J Cardiol. 2023 Nov 1;390:131233. doi: 10.1016/j.ijcard.2023.131233. Epub 2023 Jul 31.
3
Mendelian randomization study reveals a causal relationship between serum iron status and coronary heart disease and related cardiovascular diseases.孟德尔随机化研究揭示了血清铁状态与冠心病及相关心血管疾病之间的因果关系。
Front Cardiovasc Med. 2023 Jun 13;10:1152201. doi: 10.3389/fcvm.2023.1152201. eCollection 2023.
4
Causal association between placental growth factor and coronary heart disease: a Mendelian randomization study.胎盘生长因子与冠心病的因果关系:一项孟德尔随机化研究。
Aging (Albany NY). 2023 Oct 2;15(19):10117-10132. doi: 10.18632/aging.205061.
5
Bidirectional two-sample Mendelian randomization study of causality between rheumatoid arthritis and myocardial infarction.双向两样本孟德尔随机化研究类风湿关节炎与心肌梗死之间的因果关系。
Front Immunol. 2022 Dec 2;13:1017444. doi: 10.3389/fimmu.2022.1017444. eCollection 2022.
6
Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.基于孟德尔随机化分析纤维蛋白原对冠心病发病风险的因果效应。
PLoS One. 2019 May 10;14(5):e0216222. doi: 10.1371/journal.pone.0216222. eCollection 2019.
7
Causal effect of gallstone disease on the risk of coronary heart disease or acute myocardial infarction: a Mendelian randomization study.胆石病对冠心病或急性心肌梗死风险的因果关系:一项孟德尔随机化研究。
Sci Rep. 2023 Nov 1;13(1):18807. doi: 10.1038/s41598-023-46117-9.
8
No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study.血浆同型半胱氨酸水平与冠心病或急性心肌梗死风险之间无因果关系:一项孟德尔随机化研究。
Eur J Prev Cardiol. 2021 Apr 10;28(2):227–234. doi: 10.1177/2047487319894679. Epub 2019 Dec 16.
9
Association between sarcopenia-related traits and cardiovascular diseases: a bi-directional Mendelian randomization study.肌肉减少症相关特征与心血管疾病的关联:一项双向孟德尔随机化研究。
Front Endocrinol (Lausanne). 2023 Oct 13;14:1237971. doi: 10.3389/fendo.2023.1237971. eCollection 2023.
10
Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: A Mendelian randomization study.血清尿酸水平对冠心病和心肌梗死预防的性别特异性影响:一项孟德尔随机化研究。
Nutr Metab Cardiovasc Dis. 2022 May;32(5):1266-1274. doi: 10.1016/j.numecd.2022.01.022. Epub 2022 Jan 22.

引用本文的文献

1
The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes.在一项针对2型糖尿病患者的10年纵向研究中骨保护素与动脉僵硬度之间的关联。
Diab Vasc Dis Res. 2024 Nov-Dec;21(6):14791641241304435. doi: 10.1177/14791641241304435.

本文引用的文献

1
Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial.丹麦心血管疾病筛查(DANCAVAS)试验的五年结果。
N Engl J Med. 2022 Oct 13;387(15):1385-1394. doi: 10.1056/NEJMoa2208681. Epub 2022 Aug 27.
2
Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.基于 2020 年人口普查估计数的美国心血管疾病预测。
J Am Coll Cardiol. 2022 Aug 9;80(6):565-578. doi: 10.1016/j.jacc.2022.05.033.
3
Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients.
血清骨保护素是慢性肾脏病患者左心室肥厚、左心室收缩和舒张功能障碍以及心包积液的独立标志物。
Nutrients. 2022 Jul 14;14(14):2893. doi: 10.3390/nu14142893.
4
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study.2 型糖尿病合并急性冠状动脉综合征患者的蛋白质生物标志物与心血管结局:ELIXA 生物标志物研究。
Diabetes Care. 2022 Sep 1;45(9):2152-2155. doi: 10.2337/dc22-0453.
5
Association of serum sclerostin and osteoprotegerin levels with the presence, severity and prognosis in patients with acute myocardial infarction.血清骨硬化蛋白和护骨素水平与急性心肌梗死患者的存在、严重程度和预后的关系。
BMC Cardiovasc Disord. 2022 May 11;22(1):213. doi: 10.1186/s12872-022-02654-1.
6
Stem cell-derived exosomes in the treatment of acute myocardial infarction in preclinical animal models: a meta-analysis of randomized controlled trials.基于临床前动物模型的随机对照试验的荟萃分析:干细胞来源的外泌体治疗急性心肌梗死。
Stem Cell Res Ther. 2022 Apr 8;13(1):151. doi: 10.1186/s13287-022-02833-z.
7
​Circulating Cytokines in Myocardial Infarction Are Associated With Coronary Blood Flow.循环细胞因子与心肌梗死相关联的冠状动脉血流。
Front Immunol. 2022 Feb 15;13:837642. doi: 10.3389/fimmu.2022.837642. eCollection 2022.
8
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年缺血性心脏病负担及其可归因危险因素。
Eur J Prev Cardiol. 2022 Mar 11;29(2):420-431. doi: 10.1093/eurjpc/zwab213.
9
Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study.遗传易感性与处方阿片类药物使用及心血管疾病风险:多变量孟德尔随机研究。
Addiction. 2022 May;117(5):1382-1391. doi: 10.1111/add.15767. Epub 2021 Dec 22.
10
Epidemiological trends in mortality, event rates and case fatality of acute myocardial infarction from 2004 to 2015: results from the KORA MI registry.2004 年至 2015 年急性心肌梗死死亡率、事件发生率和病死率的流行病学趋势:来自 KORA MI 注册研究的结果。
Ann Med. 2021 Dec;53(1):2142-2152. doi: 10.1080/07853890.2021.2002926.